Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
341.85
549.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd
Accounts Receivables
Advanced Enzyme Technologies Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES
|
Accounts Receivables
₹987.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Akzo Nobel India Ltd
NSE:AKZOINDIA
|
Accounts Receivables
₹5.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Navin Fluorine International Ltd
NSE:NAVINFLUOR
|
Accounts Receivables
₹5.1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Asian Paints Ltd
NSE:ASIANPAINT
|
Accounts Receivables
₹47B
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
15%
|
|
|
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
|
Accounts Receivables
₹8.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Vinati Organics Ltd
NSE:VINATIORGA
|
Accounts Receivables
₹4.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
21%
|
CAGR 10-Years
13%
|
|
Advanced Enzyme Technologies Ltd
Glance View
Advanced Enzyme Technologies Ltd. engages in the research, development, manufacture, and sale of enzyme products. The company is headquartered in Thane, Maharashtra and currently employs 322 full-time employees. The company went IPO on 2016-08-01. The firm is focused on the research and development, manufacturing and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. The company provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit and vegetable processing, brewing and malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others. The company offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather and bio-fuels. Its oils and fats processing include oil extraction, oil refining fish oil processing, biodiesel and oleochemicals.
See Also
What is Advanced Enzyme Technologies Ltd's Accounts Receivables?
Accounts Receivables
987.6m
INR
Based on the financial report for Sep 30, 2024, Advanced Enzyme Technologies Ltd's Accounts Receivables amounts to 987.6m INR.
What is Advanced Enzyme Technologies Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
8%
Over the last year, the Accounts Receivables growth was -12%. The average annual Accounts Receivables growth rates for Advanced Enzyme Technologies Ltd have been 4% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
